SCHEMBL8296502

SCHEMBL8296502

Nc1nc2c(s1)CC(CC(=O)N1CCC(F)C1)CC2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.47
SCN3A Q9NY46 5/20 0.45
SCN9A Q15858 4/20 0.45
SCN5A Q14524 2/20 0.44
SCN4A P35499 1/20 0.41
DRD2 P14416 7/20 0.40
HRH2 P25021 4/20 0.39
HRH1 P35367 3/20 0.39
HRH4 Q9H3N8 3/20 0.39
HRH3 Q9Y5N1 2/20 0.39
DRD3 P35462 4/20 0.39
ADRA2A P08913 2/20 0.39
ADRB2 P07550 1/20 0.39
HTR1A P08908 1/20 0.39
ADRA2B P18089 1/20 0.39
ADRA2C P18825 1/20 0.39
DRD4 P21917 1/20 0.39
HTR1B P28222 1/20 0.39
HTR2A P28223 1/20 0.39
HTR7 P34969 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8297900 0.82 DPP4 (0.44) DPP4
SCHEMBL14370041 0.78 SCN3A (0.52) SCN3ASCN9ASCN5ASCN4ADRD2
SCHEMBL9872176 0.78 SCN3A (0.52) SCN3ASCN9ASCN5ASCN4ADRD2
SCHEMBL4869032 0.76 DPP4 (0.78) DPP4SCN3ASCN9ASCN4A
SCHEMBL9872977 0.74 KDM4E (0.59) DPP4SCN3ASCN9ASCN5ASCN4A
Water SCHEMBL9874791 0.74 KDM4E (0.58) DPP4SCN3ASCN9ASCN5ASCN4A
Water SCHEMBL9874788 0.74 KDM4E (0.58) DPP4SCN3ASCN9ASCN5ASCN4A
SCHEMBL4867798 0.73 DPP4 (0.61) DPP4SCN3ASCN9ASCN5ASCN4A
SCHEMBL8296975 0.72 TP53 (0.42)
SCHEMBL4425041 0.70 DRD2 (0.52) SCN3ASCN9ASCN5ASCN4ADRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004112701-A2 CYCLOHEXYLGLYCINE DERIVATIVES AS DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES MERCK & CO., INC. (US) 2004-12-29 WO disclosed